Home  English Website Investor relations STADA securities Official notice warrants July 2004

STADA securities

STADA Arzneimittel AG
Bad Vilbel

Official notice
to holders of warrants
issued by our company
(WKN 725 184 // ISIN DE0007251845)
and
to holders of bearer bonds with warrants attached
(WKN 106 954 // ISIN DE0001069540)

(This is a non-binding translation of the original German version.)

Following the 1:1 capital increase from existing funds resolved by the Annual Shareholders' Meeting of STADA Arzneimittel AG on June 15, 2004, the terms and conditions governing the company's warrants are to be amended as follows for the above securities with effect from August 2, 2004, pursuant to § 7 (2) of the terms and conditions governing the warrants:

With effect from August 2, 2004, each warrant shall entitle the holder to subscribe for 20 registered common shares of restricted transferability of STADA Arzneimittel AG.

The option price payable for a warrant entitling the holder in the future to subscribe for 20 shares of STADA Arzneimittel AG (§ 1 (2) sentence 1 of the terms and conditions governing the warrants) remains EUR 329. The reduced option price payable for a warrant entitling the holder to subscribe now for 20 shares of STADA Arzneimittel AG (§ 1 (2) sentence 2 of the terms and conditions governing the warrants) remains EUR 279.

The threshold price - recently adjusted to EUR 27.90 (§ 1 (2) sentence 2 of the terms and conditions governing the warrants) - shall amount to EUR 13.95 with effect from August 2, 2004.

The other terms and conditions remain unchanged.

Bad Vilbel, July 2004

STADA Arzneimittel AG

The Executive Board